2024    2023    2022    2021    2020    2019    2018    2017    2016   

2017

International refereed journal articles

11 - 

Contribution of Lower Body Lift in the Correction of Medial Thigh Deformity following Massive Weight Loss

Paul Girard, Benoit Chaput, Raphael Carloni, Eric Watier, A. de Runz, Nicolas Bertheuil

Plastic and Reconstructive Surgery, 2017, 139 (2), pp.566e--568e.

DOI : https://doi.org/10.1097/PRS.0000000000003000

Pubmed : 27741052

 

12 - 

HMGB1 induces neutrophil dysfunction in experimental sepsis and in patients who survive septic shock

Murielle Grégoire, Jean-Marc Tadié, Fabrice Uhel, Arnaud Gacouin, Caroline Piau, Nathaniel Bone, Yves Le Tulzo, Edward Abraham, Karin Tarte, Jaroslaw W. Zmijewski

Journal of Leukocyte Biology, 2017, 101 (6), pp.1281-1287.

DOI : https://doi.org/10.1189/jlb.5HI0316-128RR

Pubmed : 27965385

 

13 - 

Pericytes of Multiple Organs Do Not Behave as Mesenchymal Stem Cells In Vivo

Nuno Guimaraes-Camboa, Paola Cattaneo, Yunfu Sun, Thomas Moore-Morris, Yusu Gu, Nancy D. Dalton, Edward Rockenstein, Eliezer Masliah, Kirk L. Peterson, William B. Stallcup, Ju Chen, Sylvia M. Evans

Cell Stem Cell, 2017, 20 (3), pp.345-359.

DOI : https://doi.org/10.1016/j.stem.2016.12.006

Pubmed : 28111199

 

14 - 

Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling.

June H. Myklebust, Joshua Brody, Holbrook E. Kohrt, Arne Kolstad, Debra K. Czerwinski, Sebastien Walchli, Michael R. Green, Gunhild Troen, Knut Liestol, Klaus Beiske, Roch Houot, Jan Delabie, Ash A. Alizadeh, Jonathan M. Irish, Ronald Levy et al.

Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling. Blood, 2017, 129 (6), pp.759-770.

DOI : https://doi.org/10.1182/blood-2016-05-718494

Pubmed : 28011673

 

15 - 

IL-2 imprints human naive B cell fate towards plasma cell through ERK/ELK1-mediated BACH2 repression

Nicolas Hipp, Hannah Symington, Cédric Pastoret, Gersende Caron, Céline Monvoisin, Karin Tarte, Thierry Fest, Céline Delaloy

Nature Communications, 2017, 8 (1), pp.1443.

DOI : https://doi.org/10.1038/s41467-017-01475-7

Pubmed : 29129929

 

16 - 

Safety and efficacy of allogeneic hematopoietic stem cell transplant after PD-1 blockade in relapsed/refractory lymphoma

Roch Houot, Tony Marchand, Nathalie Dhédin, Willy Lescaut, Anne Thiebaut-Bertrand, Sylvie Francois, Aspasia Stamatoullas-Bastard, Pierre-Simon Rohrlich, Hélène Labussière Wallet, Luca Castagna, Armando Santoro, Veronika Bachanova, Scott C. Bresler, Amitabh Srivastava, Harim Kim et al.

Blood, 2017, 129 (10), pp.1380-1388.

DOI : https://doi.org/10.1182/blood-2016-09-738385

Pubmed : 28073785

 

17 - 

Characterization of human FCRL4-positive B cells

Michel Jourdan, Nicolas Robert, Maïlys Cren, Coraline Thibaut, Christophe Duperray, Alboukadel Kassambara, Michel Cogné, Karin Tarte, Bernard Klein, Jerome Moreaux

PLoS ONE, 2017, 12 (6), pp.e0179793.

DOI : https://doi.org/10.1371/journal.pone.0179793

Pubmed : 28636654

 

18 - 

Decrease of blood anti-alpha 1,3 Galactose Abs levels in multiple sclerosis (MS) and clinically isolated syndrome (CIS) patients

L. Le Berre, J. Roussé, P-A Gourraud, B-M Imbert-Marcille, A. Salama, G. Evanno, G. Semana, A. Nicot, E. Dugast, P. Guerif, C. Adjaoud, T. Freour, S. Brouard, F. Agbalika, R. Marignier et al.

Clinical Immunology, 2017, 180, pp.128-135.

DOI : https://doi.org/10.1016/j.clim.2017.05.006

Pubmed : 28506921

 

19 - 

Reduced-­intensity vs reduced­-toxicity myeloablative fludarabine/busulfan-based conditioning regimens for allografted non­Hodgkin lymphoma adult patients: a retrospective study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire.

A. Le Bourgeois, M. Labopin, D. Blaise, P. Ceballos, S. Vigouroux, R. Peffault de Latour, A. Marçais, E. Bulabois, Jo Bay, S. Chantepie, E. Deconinck, E. Daguindau, N. Contentin, I. Yakoub-Agha, J. Cornillon et al.

Reduced-­intensity vs reduced­-toxicity myeloablative fludarabine/busulfan-based conditioning regimens for allografted non­Hodgkin lymphoma adult patients: a retrospective study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire. Annals of Oncology, 2017, 28 (9), pp.2191-2198.

DOI : https://doi.org/10.1093/annonc/mdx274

Pubmed : 28911060

 

20 - 

The AID-Cre-ERT2 Model: A Tool for Monitoring B Cell Immune Responses and Generating Selective Hybridomas

Simon Le Gallou, Takuya Nojima, Daisuke Kitamura, Jean-Claude Weill, Claude-Agnès Reynaud

Methods in Molecular Biology, 2017, 1623, pp.243-251.

DOI : https://doi.org/10.1007/978-1-4939-7095-7_19

Pubmed : 28589361